Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin beta for fatigue in palliative care solid tumors
NCT00559195Phase 2Completed
- Sponsor
- CHU de Limoges
- Start
- Nov 2005
- Primary completion
- May 2011
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of epoetin beta in anemia, sponsored by CHU de Limoges. Primary endpoints: Fatigue at 12 weeks and Quality of Life at 12 weeks. Started Nov 2005; status: completed.
02
Drugs
epoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00559195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00559195.